416 related articles for article (PubMed ID: 28238669)
1. Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling.
Baluchnejadmojarad T; Rabiee N; Zabihnejad S; Roghani M
Brain Res; 2017 May; 1662():23-30. PubMed ID: 28238669
[TBL] [Abstract][Full Text] [Related]
2. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
[TBL] [Abstract][Full Text] [Related]
3. Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson's disease: Possible involvement of PI3K/ERβ signaling.
Baluchnejadmojarad T; Jamali-Raeufy N; Zabihnejad S; Rabiee N; Roghani M
Eur J Pharmacol; 2017 Apr; 801():72-78. PubMed ID: 28284752
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
[TBL] [Abstract][Full Text] [Related]
5. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
[TBL] [Abstract][Full Text] [Related]
6. Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat.
Kiasalari Z; Khalili M; Baluchnejadmojarad T; Roghani M
Neurochem Res; 2016 May; 41(5):1065-72. PubMed ID: 26700436
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2.
Jing X; Wei X; Ren M; Wang L; Zhang X; Lou H
Neurochem Res; 2016 Apr; 41(4):779-86. PubMed ID: 26537816
[TBL] [Abstract][Full Text] [Related]
8. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
Singh S; Mishra A; Shukla S
Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
[TBL] [Abstract][Full Text] [Related]
9. Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress.
Baluchnejadmojarad T; Mansouri M; Ghalami J; Mokhtari Z; Roghani M
Biomed Pharmacother; 2017 Apr; 88():754-761. PubMed ID: 28157651
[TBL] [Abstract][Full Text] [Related]
10. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.
Sarookhani MR; Haghdoost-Yazdi H; Sarbazi-Golezari A; Babayan-Tazehkand A; Rastgoo N
Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinson's Disease.
Sarkaki A; Farbood Y; Dolatshahi M; Mansouri SM; Khodadadi A
Acta Med Iran; 2016 Aug; 54(8):494-502. PubMed ID: 27701719
[TBL] [Abstract][Full Text] [Related]
12. Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.
Kiasalari Z; Baluchnejadmojarad T; Roghani M
Cell Mol Neurobiol; 2016 May; 36(4):521-30. PubMed ID: 26119304
[TBL] [Abstract][Full Text] [Related]
13. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
16. Ukgansan protects dopaminergic neurons from 6-hydroxydopamine neurotoxicity via activation of the nuclear factor (erythroid-derived 2)-like 2 factor signaling pathway.
Eo H; Huh E; Sim Y; Oh MS
Neurochem Int; 2019 Jan; 122():208-215. PubMed ID: 30508559
[TBL] [Abstract][Full Text] [Related]
17. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
[TBL] [Abstract][Full Text] [Related]
18. Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish.
Chong CM; Zhou ZY; Razmovski-Naumovski V; Cui GZ; Zhang LQ; Sa F; Hoi PM; Chan K; Lee SM
Neurosci Lett; 2013 May; 543():121-5. PubMed ID: 23562886
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway.
Zhang XS; Ha S; Wang XL; Shi YL; Duan SS; Li ZA
Neuroscience; 2015 Sep; 303():489-502. PubMed ID: 26116522
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of Nrf2-ARE activator isolated from green perilla leaves on dopaminergic neuronal loss in a Parkinson's disease model.
Masaki Y; Izumi Y; Matsumura A; Akaike A; Kume T
Eur J Pharmacol; 2017 Mar; 798():26-34. PubMed ID: 28167258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]